Corbion (CRBN) Hisse Özeti
Corbion N.V. Hollanda, Amerika Birleşik Devletleri, Asya, Kuzey Amerika'nın geri kalanı, Avrupa'nın geri kalanı, Orta Doğu ve Afrika'da laktik asit ve laktik asit türevleri, gıda koruma çözümleri, fonksiyonel karışımlar ve alg bileşenleri sağlamaktadır. Daha fazla detay
| Kar Tanesi Skoru | |
|---|---|
| Değerleme | 5/6 |
| Gelecekteki Büyüme | 1/6 |
| Geçmiş Performans | 4/6 |
| Finansal Sağlık | 5/6 |
| Temettüler | 3/6 |
Ödüller
Risk Analizi
CRBN Community Fair Values
Create NarrativeSee what 26 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Corbion N.V. Rakipler
Fiyat Geçmişi ve Performans
| Tarihsel hisse senedi fiyatları | |
|---|---|
| Güncel Hisse Fiyatı | €18.82 |
| 52 Haftanın En Yüksek Seviyesi | €21.64 |
| 52 Haftanın En Düşük Seviyesi | €16.16 |
| Beta | 0.91 |
| 1 Aylık Değişim | -1.77% |
| 3 Aylık Değişim | -9.95% |
| 1 Yıllık Değişim | -0.21% |
| 3 Yıllık Değişim | -30.55% |
| 5 Yıllık Değişim | -62.30% |
| Halka arzdan bu yana değişim | -28.08% |
Son Haberler & Güncellemeler
Anlatı Güncellemesi • May 09
CRBN: Special Dividend And Higher Future P E Could Support Re Rating
Analysts have reduced their fair value estimate for Corbion from €30.00 to €28.00, citing updated assumptions for revenue growth, profit margins and future P/E following recent research, including the Barclays downgrade. Analyst Commentary Recent research has led to a lower fair value estimate for Corbion, but bullish analysts still highlight several supports for the stock, focusing on how current assumptions around revenue, margins and P/E could play out over time.
Anlatı Güncellemesi • Apr 22
CRBN: Special Dividend And Execution On Margins Will Support Upside Potential
The updated analyst price target for Corbion has shifted slightly to about €24.03 from €24.17, as analysts adjust their assumptions around discount rate, revenue growth, profit margin and future P/E in light of recent research, including the Barclays downgrade. Analyst Commentary Bullish Takeaways Bullish analysts see the updated price target around €24.03 as still leaving some room for upside if Corbion executes well on its revenue and margin assumptions embedded in the models.Recent updates
Anlatı Güncellemesi • May 09
CRBN: Special Dividend And Higher Future P E Could Support Re Rating
Analysts have reduced their fair value estimate for Corbion from €30.00 to €28.00, citing updated assumptions for revenue growth, profit margins and future P/E following recent research, including the Barclays downgrade. Analyst Commentary Recent research has led to a lower fair value estimate for Corbion, but bullish analysts still highlight several supports for the stock, focusing on how current assumptions around revenue, margins and P/E could play out over time.Anlatı Güncellemesi • Apr 22
CRBN: Special Dividend And Execution On Margins Will Support Upside Potential
The updated analyst price target for Corbion has shifted slightly to about €24.03 from €24.17, as analysts adjust their assumptions around discount rate, revenue growth, profit margin and future P/E in light of recent research, including the Barclays downgrade. Analyst Commentary Bullish Takeaways Bullish analysts see the updated price target around €24.03 as still leaving some room for upside if Corbion executes well on its revenue and margin assumptions embedded in the models.
Anlatı Güncellemesi • Apr 08
CRBN: Raised Fair Value And Barclays Downgrade Will Shape Risk Balance
Analysts now set Corbion's fair value at €19.60, up from €18.60. This reflects updated assumptions on growth, margins and P/E multiples, even as some recent research, including a downgrade at Barclays, highlights ongoing risks.Anlatı Güncellemesi • Mar 24
CRBN: Higher Margins And Special Dividend Will Support Future Re Rating
Analysts have maintained their price target for Corbion at €30.00, citing updated assumptions around the discount rate, revenue growth, profit margin and future P/E as the main factors supporting the unchanged view. What's in the News Corbion N.V. proposed a special dividend of €0.36 per share, planned for distribution in 2025.Anlatı Güncellemesi • Mar 10
CRBN: Special Dividend And Stronger Margins Will Support A More Optimistic Outlook
Analysts have trimmed their price target on Corbion from €24.60 to about €24.17, reflecting updated views on its projected revenue growth, profit margins, and future P/E assumptions. What's in the News Corbion N.V. proposed a special dividend of €0.36 per share for 2025, which may influence your expected cash returns from holding the stock (Key Developments).Anlatı Güncellemesi • Feb 24
CRBN: Higher Future P/E Assumptions Will Support A More Optimistic Outlook
Analysts have raised their price target on Corbion from about €22.73 to €24.60, citing updated assumptions on discount rates, revenue growth, profit margins, and future P/E levels. Valuation Changes Fair Value: Updated estimate increased from about €22.73 to €24.60 per share.Anlatı Güncellemesi • Feb 09
CRBN: Buyback And Higher Discount Rate Will Pressure Overvalued Shares
Analysts have kept their price target on Corbion steady at €18.60, citing only small adjustments to assumptions around the discount rate, revenue trends, profit margins and future P/E as the basis for this unchanged view. What's in the News Corbion completed a share buyback program, repurchasing 577,615 shares for €10 million, equal to 0.99% of the company.Anlatı Güncellemesi • Jan 26
CRBN: Higher Future P/E And Execution Risks Will Shape EUR 18 Outlook
Narrative Update on Corbion Analysts have raised their fair value estimate for Corbion to €18.60 from €18.00. This reflects updated views on discount rates, long term revenue trends, profit margins, and a higher future P/E assumption, alongside recent Street research where a key price target moved to €18 from €16.50.Analiz Makalesi • Jan 14
Should You Think About Buying Corbion N.V. (AMS:CRBN) Now?
Corbion N.V. ( AMS:CRBN ), is not the largest company out there, but it saw a double-digit share price rise of over 10...Anlatı Güncellemesi • Jan 11
CRBN: Future P/E Reset And Margin Assumptions Will Shape EUR 18 Outlook
Analysts have raised their price target for Corbion to €18 from €16.50, citing updated assumptions on revenue trends, margins and future P/E as the main factors behind the change. Analyst Commentary The revised €18 price target still comes with a Hold stance, which signals a measured view on Corbion.Anlatı Güncellemesi • Dec 26
CRBN: Higher EUR 18 Outlook Will Test Margin Delivery Amid Muted Demand
Analysts have raised their fair value estimate for Corbion to EUR 18 from EUR 14, reflecting increased confidence in the company’s profit margin outlook and a willingness to apply a higher future earnings multiple despite more muted revenue growth expectations. Analyst Commentary Bearish analysts acknowledge the higher fair value estimate but continue to highlight a cautious stance on Corbion’s near term prospects, emphasizing that the improved target largely reflects valuation mechanics rather than a fundamental re-rating of the growth outlook.Anlatı Güncellemesi • Dec 12
CRBN: Margin Improvements And Buybacks Will Support A Future Re-Rating
Analysts have lowered their fair value price target on Corbion to EUR 30.00 from EUR 31.90, citing tempered expectations for long term revenue growth and profit margins, even as some recent Street research has modestly raised nearer term share price targets. Analyst Commentary Bullish analysts highlight that the recent upward revision in near term price targets, even from a relatively low base, reflects growing confidence that Corbion can stabilize its earnings profile and execute on margin improvement initiatives.Analiz Makalesi • Nov 14
Corbion N.V. (AMS:CRBN) Shares Could Be 35% Below Their Intrinsic Value Estimate
Key Insights Using the 2 Stage Free Cash Flow to Equity, Corbion fair value estimate is €28.50 Current share price of...Analiz Makalesi • Jun 23
Corbion N.V.'s (AMS:CRBN) Intrinsic Value Is Potentially 65% Above Its Share Price
Key Insights The projected fair value for Corbion is €30.72 based on 2 Stage Free Cash Flow to Equity Current share...Analiz Makalesi • May 07
Here's Why Shareholders Should Examine Corbion N.V.'s (AMS:CRBN) CEO Compensation Package More Closely
Key Insights Corbion's Annual General Meeting to take place on 14th of May Salary of €725.0k is part of CEO Olivier...Analiz Makalesi • Apr 10
At €17.39, Is Corbion N.V. (AMS:CRBN) Worth Looking At Closely?
Corbion N.V. ( AMS:CRBN ), might not be a large cap stock, but it saw significant share price movement during recent...Analiz Makalesi • Mar 26
Corbion's (AMS:CRBN) Earnings May Just Be The Starting Point
Corbion N.V.'s ( AMS:CRBN ) earnings announcement last week was disappointing for investors, despite the decent profit...
Yeni Anlatı • Mar 02
Expanding Into Natural Antioxidants And Efficiency Improvements Will Drive Future Success
Strategic initiatives and operational optimizations are expected to significantly enhance EBITDA margins and net margins.Analiz Makalesi • Feb 28
Here's What To Make Of Corbion's (AMS:CRBN) Decelerating Rates Of Return
What are the early trends we should look for to identify a stock that could multiply in value over the long term...Analiz Makalesi • Dec 18
Risks To Shareholder Returns Are Elevated At These Prices For Corbion N.V. (AMS:CRBN)
It's not a stretch to say that Corbion N.V.'s ( AMS:CRBN ) price-to-earnings (or "P/E") ratio of 15.8x right now seems...Analiz Makalesi • Nov 18
Should You Think About Buying Corbion N.V. (AMS:CRBN) Now?
Corbion N.V. ( AMS:CRBN ), might not be a large cap stock, but it received a lot of attention from a substantial price...Analiz Makalesi • Oct 31
An Intrinsic Calculation For Corbion N.V. (AMS:CRBN) Suggests It's 26% Undervalued
Key Insights Using the 2 Stage Free Cash Flow to Equity, Corbion fair value estimate is €31.60 Corbion's €23.28 share...Analiz Makalesi • Sep 26
Corbion (AMS:CRBN) Takes On Some Risk With Its Use Of Debt
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Analiz Makalesi • Jul 18
The Price Is Right For Corbion N.V. (AMS:CRBN)
It's not a stretch to say that Corbion N.V.'s ( AMS:CRBN ) price-to-earnings (or "P/E") ratio of 16.1x right now seems...Analiz Makalesi • Jun 20
Corbion N.V. (AMS:CRBN) Shares Could Be 25% Below Their Intrinsic Value Estimate
Key Insights Using the 2 Stage Free Cash Flow to Equity, Corbion fair value estimate is €25.18 Corbion is estimated to...Analiz Makalesi • May 08
Here's Why Shareholders Should Examine Corbion N.V.'s (AMS:CRBN) CEO Compensation Package More Closely
Key Insights Corbion will host its Annual General Meeting on 15th of May Salary of €713.0k is part of CEO Olivier...Analiz Makalesi • Apr 17
Does Corbion (AMS:CRBN) Have A Healthy Balance Sheet?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Analiz Makalesi • Jan 20
Investor Optimism Abounds Corbion N.V. (AMS:CRBN) But Growth Is Lacking
There wouldn't be many who think Corbion N.V.'s ( AMS:CRBN ) price-to-earnings (or "P/E") ratio of 14.3x is worth a...Analiz Makalesi • Dec 18
Should You Think About Buying Corbion N.V. (AMS:CRBN) Now?
Corbion N.V. ( AMS:CRBN ), might not be a large cap stock, but it saw a decent share price growth in the teens level on...Analiz Makalesi • Nov 04
Estimating The Fair Value Of Corbion N.V. (AMS:CRBN)
Key Insights Using the 2 Stage Free Cash Flow to Equity, Corbion fair value estimate is €15.91 Corbion's €17.30 share...Analiz Makalesi • Sep 13
Corbion (AMS:CRBN) Has A Somewhat Strained Balance Sheet
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...Analiz Makalesi • Aug 04
Returns On Capital Signal Tricky Times Ahead For Corbion (AMS:CRBN)
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Ideally, a...Analiz Makalesi • Jul 14
When Should You Buy Corbion N.V. (AMS:CRBN)?
While Corbion N.V. ( AMS:CRBN ) might not be the most widely known stock at the moment, it received a lot of attention...Analiz Makalesi • Jun 04
Corbion N.V. (AMS:CRBN) Shares Could Be 22% Above Their Intrinsic Value Estimate
Key Insights The projected fair value for Corbion is €21.22 based on 2 Stage Free Cash Flow to Equity Current share...Analiz Makalesi • Apr 21
Here's Why Corbion (AMS:CRBN) Has A Meaningful Debt Burden
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Analiz Makalesi • Mar 10
Corbion (AMS:CRBN) Is Paying Out A Dividend Of €0.56
Corbion N.V. ( AMS:CRBN ) has announced that it will pay a dividend of €0.56 per share on the 30th of May. The dividend...Analiz Makalesi • Feb 22
Is Now An Opportune Moment To Examine Corbion N.V. (AMS:CRBN)?
Corbion N.V. ( AMS:CRBN ), is not the largest company out there, but it received a lot of attention from a substantial...Analiz Makalesi • Jan 26
Corbion's (AMS:CRBN) Returns On Capital Not Reflecting Well On The Business
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Firstly, we'll...Analiz Makalesi • Dec 20
Is Corbion (AMS:CRBN) Using Too Much Debt?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...Analiz Makalesi • Nov 24
Calculating The Intrinsic Value Of Corbion N.V. (AMS:CRBN)
Today we will run through one way of estimating the intrinsic value of Corbion N.V. ( AMS:CRBN ) by taking the expected...Analiz Makalesi • Nov 09
Should You Think About Buying Corbion N.V. (AMS:CRBN) Now?
Corbion N.V. ( AMS:CRBN ), might not be a large cap stock, but it saw a decent share price growth in the teens level on...Analiz Makalesi • Oct 08
Corbion (AMS:CRBN) Might Be Having Difficulty Using Its Capital Effectively
Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...Hissedar Getirileri
| CRBN | NL Chemicals | NL Pazar | |
|---|---|---|---|
| 7D | -2.3% | 1.9% | 0.9% |
| 1Y | -0.2% | -27.2% | 23.2% |
Getiri vs. Endüstri: CRBN geçen yıl % -27.2 oranında getiri sağlayan Dutch Chemicals sektörünü aştı.
Getiri vs Piyasa: CRBN geçen yıl % 23.2 oranında getiri sağlayan Dutch Piyasasının altında performans gösterdi.
Fiyat Oynaklığı
| CRBN volatility | |
|---|---|
| CRBN Average Weekly Movement | 4.1% |
| Chemicals Industry Average Movement | 4.1% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in NL Market | 7.6% |
| 10% least volatile stocks in NL Market | 2.8% |
İstikrarlı Hisse Senedi Fiyatı: CRBN son 3 ayda Dutch piyasasına kıyasla önemli bir fiyat oynaklığı yaşamadı.
Zaman İçindeki Volatilite: CRBN 'nin haftalık oynaklığı ( 4% ) son bir yıldır istikrarlı seyretti.
Şirket Hakkında
| Kuruldu | Çalışanlar | CEO | Web sitesi |
|---|---|---|---|
| 1903 | 2,410 | Olivier Rigaud | www.corbion.com |
Corbion N.V. Hollanda, Amerika Birleşik Devletleri, Asya, Kuzey Amerika'nın geri kalanı, Avrupa'nın geri kalanı, Orta Doğu ve Afrika'da laktik asit ve laktik asit türevleri, gıda koruma çözümleri, fonksiyonel karışımlar ve alg bileşenleri sunmaktadır. Şirket, Fonksiyonel Bileşenler ve Çözümler ile Sağlık ve Beslenme segmentleri aracılığıyla faaliyet göstermektedir. Şirket asitlendirme, renk tutma, dekontaminasyon, gıda güvenliği ve koruma, tazelik ve raf ömrü, sağlık ve beslenme, güçlendirme koşullandırma ve tat ve doku gıda çözümleri; bir dizi özel sentez seçeneği sunan bir çözüm olan Purasorb Ar-Ge; çözücülük, antimikrobiyal, nemlendirme ve ilaç gibi biyokimyasal uzmanlık çözümleri; ve balık yağının yerini alma ve sürdürülebilir omega-3 kaynağı dahil olmak üzere alg bileşenleri çözümleri sunmaktadır.
Corbion N.V. Temel Bilgiler Özeti
| CRBN temel i̇stati̇sti̇kler | |
|---|---|
| Piyasa değeri | €1.08b |
| Kazançlar(TTM) | €74.80m |
| Gelir(TTM) | €1.27b |
14.5x
F/K Oranı0.9x
P/S OranıCRBN aşırı değerli mi?
Gerçeğe Uygun Değer ve değerleme analizine bakınızKazanç ve Gelir
| CRBN gelir tablosu (TTM) | |
|---|---|
| Gelir | €1.27b |
| Gelir Maliyeti | €932.70m |
| Brüt Kâr | €334.70m |
| Diğer Giderler | €259.90m |
| Kazançlar | €74.80m |
Son Raporlanan Kazançlar
Dec 31, 2025
Sonraki Kazanç Tarihi
Jul 31, 2026
| Hisse başına kazanç (EPS) | 1.30 |
| Brüt Marj | 26.41% |
| Net Kâr Marjı | 5.90% |
| Borç/Özkaynak Oranı | 53.8% |
CRBN uzun vadede nasıl bir performans gösterdi?
Geçmiş performansı ve karşılaştırmayı görünTemettüler
3.4%
Mevcut Temettü Verimi50%
Ödeme OranıCRBN güvenilir bir temettü ödüyor mu?
CRBN temettü geçmişine ve kıyaslamalara bakın| Corbion temettü tari̇hleri̇ | |
|---|---|
| Eski Temettü Tarihi | May 15 2026 |
| Temettü Ödeme Tarihi | May 22 2026 |
| Eski temettüye kadar geçen günler | 6 days |
| Temettü ödeme tarihine kadar geçen günler | 1 day |
CRBN güvenilir bir temettü ödüyor mu?
CRBN temettü geçmişine ve kıyaslamalara bakınŞirket Analizi ve Finansal Veri Durumu
| Veri | Son Güncelleme (UTC saati) |
|---|---|
| Şirket Analizi | 2026/05/20 01:52 |
| Gün Sonu Hisse Fiyatı | 2026/05/20 00:00 |
| Kazançlar | 2025/12/31 |
| Yıllık Kazançlar | 2025/12/31 |
Veri Kaynakları
Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.
| Paket | Veri | Zaman Çerçevesi | Örnek ABD Kaynağı * |
|---|---|---|---|
| Şirket Finansalları | 10 yıl |
| |
| Analist Konsensüs Tahminleri | +3 yıl |
|
|
| Piyasa Fiyatları | 30 yıl |
| |
| Sahiplik | 10 yıl |
| |
| Yönetim | 10 yıl |
| |
| Önemli Gelişmeler | 10 yıl |
|
* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılmıştır.
Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Daha fazla bilgi edinin.
Analiz Modeli ve Kar Tanesi
Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntılarına GitHub sayfamızdan ulaşabilirsiniz, ayrıca raporlarımızı nasıl kullanacağınızı anlatan kılavuzlarımız ve Youtube'da eğitim videolarımız da bulunmaktadır.
Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.
Endüstri ve Sektör Metrikleri
Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları Github'da mevcuttur.
Analist Kaynakları
Corbion N.V. 13 Bu analistlerden 6, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.
| Analist | Kurum |
|---|---|
| Setu Sharda | Barclays |
| Sebastian Bray | Berenberg |
| Fintan Ryan | Berenberg |